Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of non-modifiable risk factors of Alzheimer’s disease on intracortical myelin content ; volume:14 ; number:1 ; day:31 ; month:12 ; year:2022 ; pages:1-13 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (31.12.2022), 1-13, 12.2022
- Creator
-
Fernandez-Alvarez, Marina
Atienza, Mercedes
Cantero, Jose L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01152-y
- URN
-
urn:nbn:de:101:1-2023031109374802477017
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fernandez-Alvarez, Marina
- Atienza, Mercedes
- Cantero, Jose L.
- SpringerLink (Online service)
Other Objects (12)
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Myelin in Alzheimer’s disease: culprit or bystander?
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
Genetics of Alzheimer’s disease
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Myelin in Alzheimer’s disease: culprit or bystander?
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease
Genetics of Alzheimer’s disease
The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention
Myelin in Alzheimer’s disease: culprit or bystander?
Changes of Myelin Organization in Patients with Alzheimer’s Disease Shown by q-Space Myelin Map Imaging
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease
Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Ageing-associated myelin dysfunction as a driver of amyloid deposition in Alzheimer’s disease
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer’s disease